Highlights
The NGO sought exemption of COVID-19 related drugs, medical equipment, other medical treatment for infection prevention, control measures and supportive care for patients from GST
The rate of infection, the positivity rate, as well as the rate of hospitalization for those requiring critical treatment have all increased exponentially with double mutant virus
The plea said that section 11 of the CGST Act confers the power of exemption from payment of GST on goods and services to the GST Council
New Delhi: A plea has been filed in the Supreme Court seeking GST exemption for Remdesivir, Tocilizumab, Favipiravir and other COVID-19 related drugs with a similar generic constitution as well as medical equipment.
Synopsis
The application sought direction to the Centre to issue appropriate ad-hoc guidelines, orders or notifications exempting COVID-19 related drugs including but not limited to Remdesivir, Tocilizumab, Favipiravir and other drugs with similar generic constitution, medical equipment including but not limited to Ventilators and Bipap Machines, and other medical treatment.
It said that the 42nd GST Council Meeting was held on October 5, 2020, that is after the use of an antiviral drug named Remdesivir was found to be a part of the uniformly acceptable part of treatment protocol.
A plea has been filed in the Supreme Court seeking GST exemption for Remdesivir, Tocilizumab, Favipiravir and other COVID-19 related drugs with similar generic constitution as well as medical equipment. The intervention application has been filed by an NGO, Public Policy Advocates , in the pending suo motu case by the apex court on distribution of essential supplies and services during pandemic.
The intervention application has been filed by an NGO, Public Policy Advocates , in the pending suo motu case by the apex court on distribution of essential supplies and services during pandemic.
Limited stock of Covid drug Tocilizumab imported, allocated to states
By IANS |
2 Views
. Image Source: IANS News
New Delhi, April 28 : Tocilizumab, prescribed for treatment of some Covid-19 patients under certain conditions, went out of stock in the country a few weeks ago due to a sudden surge in its demand and fresh limited stocks have been imported in India, the Prime Minister s Office was informed.
The Health and Family Welfare Ministry and the Department of Pharmaceuticals had alerted the PMO and the Ministry of Home Affairs that Tocilizumab was out of stock and a limited amount of it have been allocated to the states facing severe surge in Covid cases.
Why India should prepare for COVID-19 recovered patients as next big health crisis downtoearth.org.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from downtoearth.org.in Daily Mail and Mail on Sunday newspapers.